செயலில் மருந்துகள் பொருட்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from செயலில் மருந்துகள் பொருட்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In செயலில் மருந்துகள் பொருட்கள் Today - Breaking & Trending Today

PI Industries to acquire API biz from Ind-Swift Labs

PI Industries to acquire API biz from Ind-Swift Labs
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Pharmaceuticals Ingredients , Pi Industries , Ind Swift Laboratories , Active Pharmaceuticals Ingredients , Ind Swift , மருந்துகள் பொருட்கள் , பி தொழில்கள் , இந்த் ஸ்விஃப்ட் ஆய்வகங்கள் , செயலில் மருந்துகள் பொருட்கள் , இந்த் ஸ்விஃப்ட் ,

Breaking News | PSN Applauds As AfDB Is Set To Invest $3bn In Africa's Pharmaceutical Industry

Views: Visits
7
Pharmaceutical Society of Nigeria, PSN By Chioma Obinna President of the Pharmaceutical Society of Nigeria PSN, Pharm Sam Ohuabunwa weekend lauded the African Development Bank AfDB on its decision to invest 3 billion dollars ($3 billion) to build Africa’s pharmaceutical industry in the next 10 years as well as support the Africa Centre for Disease Control, Africa CDC, with 28 million dollars to strengthen its capacity to ensure the manufacture of vaccines in the continent.
Ohuabunwa said PSN cannot agree more with the President, AfDB, Dr Akinwumi Adesina statement during a meeting themed ‘Africa’s Green and Resilient Recovery: A Common Objective’, in his submission. “Let’s finance in common and build a common positive story of innovation and investment in Africa, leveraging and mobilising all willing stakeholders. The days of pure aid are over. Africa is ready for sustainable investment.” ....

Chioma Obinna , Akinwumi Adesina , Pharm Sam Ohuabunwa , Society Of Nigeria , Community Pharmacies , Africa Centre For Disease , Pharmaceuticals Ingredients Apis , African Development Bank Af , Chioma Obinna President , Pharmaceutical Society , African Development Bank , Africa Centres , Disease Control , Resilient Recovery , Common Objective , Active Pharmaceuticals Ingredients , Pharmaceutical Sector , Pharmaceutical Care , சமூகம் ஆஃப் நைஜீரியா , சமூக மருந்தகங்கள் , மருந்துகள் பொருட்கள் ஆபிஸ் , மருந்து சமூகம் , நோய் கட்டுப்பாடு , நெகிழக்கூடிய மீட்பு , பொதுவானது புறநிலை , செயலில் மருந்துகள் பொருட்கள் ,

Divis Lab Q3 rises over 31% YoY in Q3 FY21

On a consolidated basis, Divi s Laboratories reported 31.1% jump in net profit to Rs 470.62 crore on a 21.9% rise in net sales to Rs 1701.44 crore in Q3 FY21 over Q3 FY20.
The company reported a forex gain of Rs 2.53 crore in the quarter ended December 2020 as against a forex gain of Rs 17.96 crore in the quarter ended December 2019.
Profit before tax in Q3 December 2020 stood at Rs 642.08 crore, up by 31.8% from Rs 487.32 crore in Q3 December 2019. Current tax expenses during the quarter increased by 18.4% year-on-year (YoY) to Rs 144.78 crore.
The company has been able to have normalized operations during the quarter, Divi s Lab said in a statement. ....

Divi Lab , Capital Market , Divis Laboratories , Active Pharmaceuticals Ingredients , Divis Lab , டிவி ஆய்வகம் , மூலதனம் சந்தை , டிவிஸ் ஆய்வகங்கள் , செயலில் மருந்துகள் பொருட்கள் , டிவிஸ் ஆய்வகம் ,